Screener
Arbutus Biopharma Corporation ABUS Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 7:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001447028-26-000021
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Basic | $0.88 | $(0.13) |
| Diluted | $0.87 | $(0.13) |
| Weighted average number of common shares | ||
| Basic | 193,768,641 | 190,707,085 |
| Diluted | 195,214,067 | 190,707,085 |
| Comprehensive income (loss) | ||
| Unrealized loss on available-for-sale securities | $(97) | $(31) |
| Comprehensive income (loss) | $169,598 | $(24,557) |
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
FAQ
- What is Arbutus Biopharma Corporation's shares (diluted)?
- Arbutus Biopharma Corporation (ABUS) reported shares (diluted) of 195.2M in Q1 2026.
- How has Arbutus Biopharma Corporation's shares (diluted) changed year-over-year?
- Arbutus Biopharma Corporation's shares (diluted) increased by 2.4% year-over-year, from 190.7M to 195.2M.
- What is the long-term trend for Arbutus Biopharma Corporation's shares (diluted)?
- Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's shares (diluted) has grown at a 17.8% compound annual growth rate (CAGR), from 397.8M to 766.5M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Arbutus Biopharma Corporation's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude